Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Learn various ways to save money while studying, helping you build your financial skills and enjoy a more manageable budget during college.
27,538 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Weekly jobless claims dropped to the year's low, a sign that the labor market may be stabilizing even as some sectors...
The Commerce Department reports 2025 trade data showing a modest narrowing of the U.S. deficit to about $901 billion,...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
Société Générale’s SG-FORGE unit has moved EUR CoinVertible onto the XRP Ledger, joining Ethereum and Solana in a swe...
Delta expects halt flights at NYC and Boston hubs as a blizzard bears down on the Northeast, disrupting travel plans ...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Home Depot posts a solid Q4 with adjusted EPS of $2.72 on revenue of $38.2 billion, beating estimates for the first t...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...